ReForm Biologics announces issuance of U.S. Patent on stabilizing excipients for therapeutic protein formulations
Wednesday, May 08, 2019 ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing,
Read More